Intraocular levels of methotrexate after oral low-dose treatment in chronic uveitis

Ophthalmologica

Volumn 219, Issue 1, 2005, Pages 54-55

  Puchta, Joachim ^a,c   Hattenbach, Lars Olof ^a   Baatz, Holger ^b  

^a GOETHE UNIVERSITY   (Germany)

^b Recklinghausen Eye Center   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Methotrexate, intraocular; Uveitis

Indexed keywords

METHOTREXATE;

ADOLESCENT; AQUEOUS HUMOR; ARTICLE; CASE REPORT; CATARACT EXTRACTION; DRUG BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; LOW DRUG DOSE; SERUM; UVEITIS;

ADMINISTRATION, ORAL; ADOLESCENT; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; UVEITIS;

EID: 11844300398     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081784     Document Type: Article

References (10)

1. Holz FG, Krastel H, Breitbart A, Schwarz-Eywill M, Pezzutto A, Volcker HE: Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids. Ger J Ophthalmol 1992;1:142-144.
2. Wong VG, Hersh EM: Methotrexate in the therapy of cyclitis. Trans Am Acad Ophthalmol Otolaryngol 1965;69:279-293.
3. Ravelli I, Martini H: Methotrexate in juvenile idiopathic arthritis: Answers and questions. J Rheumatol 2000;27:1830-1833.
4. De Smet MD, Stark-Vancs V, Kohler DR, Smith J, Wittes R, Nussenblatt RB: Intraocular levels of methotrexate after intravenous administration. Am J Ophthalmol 1996;121:442-444.
5. Henson JW, Yang J, Batchelor TT: Intraocular methotrexate levels after high-dose intravenous infusion. J Clin Oncol 1999;17:1329.
6. Kurnik D, Loebstein, Fishbein E, Almog S, Halkin H, Bar-Meir S, Chowers Y: Bioavailability of oral vs subcutaneous low-dose methotrexate in patients with Crohn's disease. Aliment Pharmacol Ther 2003;18:57-63.
7. Oguey D, Kolliker F, Gerber NJ, Reichen J: Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:611-614.
8. Hamilton RA, Kremer JM: Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. Br J Rheumatol 1997;36:86-90.
9. Chladek J, Grim J, Martinkova J, Simkova M, Vaniekova J, Koudelkova V, Noiekova M: Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis. Br J Clin Pharmacol 2002;54:147-156.
10. Bannwarth B, Pehourcq F, Schaeverbeke T, Dehais J: Clinical pharmacokinetics of low dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet 1996;30:194-210.